Polycystic Ovary Syndrome (PCOS)

Elaris PCOS I

"Study of the Safety and Efficacy of Elagolix in Women with Polycystic Ovary Syndrome"

Investigator: Stephen Fehnel, MD

The study will assess the potential impact of Elagolix on disordered pituitary and ovarian hormones in women with Polycystic Ovary Syndrome (PCOS).

Learn more about the PCOS trial.

View on ClinicalTrials.gov or call the Clinical Trials Office at 484-628-8585 for more information.


Pregnancy

MATISSE

"A Phase 3 Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy"

Investigator: Mark Martens, MD

The study will assess the safety and efficacy of an RSV vaccine in pregnant women and infants.

Learn more about the MATISSE trial.

View on ClinicalTrials.gov or call the Clinical Trials Office at 484-628-8585 for more information.


Sterilization

POET

"Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization"

Investigator: Stephen Fehnel, MD

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization. This study is closed to enrollment.

Learn more about the POET trial.

View on ClinicalTrials.gov or call the Clinical Trials Office at 484-628-8585 for more information.


Urinary Tract Infection (UTI)

EAGLE 2

"A Study of Evaluate the Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)"

Investigator: Stephen Fehnel, MD

This study will evaluate the therapeutic response of oral gepotidacin compared to oral nitrofurantoin for uncomplicated UTI in adolescent and adult female subjects. For this study, Reading Hospital will only be enrolling women >18 years.

Learn more about the EAGLE 2 trial.

View on ClinicalTrials.gov or call the Clinical Trials Office at 484-628-8585 for more information.